GLUTATHIONE REDUCTASE
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, CONJUGATE PATHWAY
(R)-(-)-NIRVANOL
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
OXIDIZED NIFEDIPINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
MIDAZOLAM-(METHYL,1,3A,4-13C4-5-15N) MALEATE SALT, DEA SCHEDULE III
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
(R)-(-)-MEPHENYTOIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
TERFENADINE ALCOHOL METABOLITE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
UDP-GLYCOSYLTRANSFERASE 2B7 ISOZYME
UDP-Glucuronosyltransferase 2B7 Isozyme human, baculovirus-infected Sf9 cells, buffered aqueous glycerol solution, main >= 0.25units/mg protein
6-HYDROXYCHLORZOXAZONE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
MEFENAMIC ACID
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
TOLMETIN SODIUM DIHYDRATE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS